2'-Deoxycytidine hydrochloride - CAS 3992-42-5
Not Intended for Therapeutic Use. For research use only.
Product Name:
2'-Deoxycytidine hydrochloride
Catalog Number:
2'-Deoxycytidine monohydrochloride; Deoxycytidine hydrochloride; NSC 83251
CAS Number:
2'-Deoxyguanosine HCl is composed of the purine nucleoside guanine linked by its N9 nitrogen to the C1 carbon of deoxyribose.
Molecular Weight:
Molecular Formula:
Chemical Structure
CAS 3992-42-5 2'-Deoxycytidine hydrochloride

Related Products

Cgp 43902A
(CAS: 124076-31-9)

Cgp 43902A is a bio-active molecular, but no detailed information has been published yet.

CAS 4360-12-7 Ajmaline:Ajmalan-17,21-diol,(17R,21)-,

(CAS: 4360-12-7)

Ajmaline is an alkaloid which could extracted from Rauwolfia serpentina. It is an antiarrhythmic agent, acting through changing the shreshold and the shape of c...

CAS 4727-31-5 Kartogenin

(CAS: 4727-31-5)

Kartogenin induces the selective differentiation of multipotent mesenchymal stem cells (MSCs) into chondrocytes. Kartogenin binds to filamin A, and disrupts the...

CAS 512-04-9 Diosgenin

(CAS: 512-04-9)

Diosgenin, a steroid sapogenin, is the product of hydrolysis by acids, strong bases, or enzymes of saponins, extracted from the tubers of Dioscorea wild yam, su...

CAS 1579991-63-1 Chitinase-IN-2

(CAS: 1579991-63-1)

Chitinase-IN-2 is a insect chitinase and N- acetyl hexosaminidase inhibitor and pesticide; 50 uM/20uM compound concentration's inhibitory percentage are 98%...

CAS 38642-49-8 Benzoylpaeoniflorin

(CAS: 38642-49-8)

Benzoylpaeoniflorin was found to be active against cyclooxygenase-1 and cyclooxygenase-2 enzymes.

CAS 1094-61-7 β-Nicotinamide Mononucleotide

β-Nicotinamide Mononucleotide
(CAS: 1094-61-7)

β-Nicotinamide mononucleotide, a main product of extracellular NAMPT reaction, could ameliorate glucose intolerance and also increase hepatic insulin sensitivit...

(CAS: 1027099-03-1)

Tomicorat is used as an anti-inflammatory agent.

CAS 191282-48-1 C75 trans

C75 trans
(CAS: 191282-48-1)

trans-Tetrahydro-4-methylene-2-octyl-5-oxo-3-furancarboxylic Acid is a well-known fatty acid synthase (FAS) inhibitor. Studies show that trans-Tetrahydro-4-meth...

CAS 3184-59-6 Alipamide

(CAS: 3184-59-6)

Alipamide is a bio-active chemical with a sequence-specific threading tetra-intercalator with an extremely slow dissociation rate constant.

CAS 182431-12-5 Lomitapide

(CAS: 182431-12-5)

Lomitapide is a potent microsomal triglyceride transfer protein (MTP) inhibitor, used in the treatment of familial hypercholesterolemia.

CAS 645-43-2 Guanethidine sulfate

Guanethidine sulfate
(CAS: 645-43-2)

Guanethidine is an antihypertensive drug that reduces the release of catecholamines, such as norepinephrine. It is transported across the sympathetic nerve memb...

CAS 66-97-7 Psoralen

(CAS: 66-97-7)

Psoralen is an active ingredient from Fructus Psoraleae and has anticancer activity.

CAS 6233-83-6 Oxytocin acetate

Oxytocin acetate
(CAS: 6233-83-6)

Oxytocin acetate is a mammalian neurohypophysial hormone. Its actions are mediated by specific, high-affinity oxytocin receptors. Oxytocin is normally produced ...

(CAS: 796874-99-2)

KYP-2047 is a selective Prolyl oligopeptidase inhibitor. And it is also known as prolyl endopeptidase. KYP-2047 can reduce α-synuclein protein levels and aggreg...

CAS 532-11-6 Anethole trithione

Anethole trithione
(CAS: 532-11-6)

Anethole trithione is a antitumor agent used in the treatment of dry mouth

(CAS: 1334310-70-1)

SS5020 is a novel benzopyran antiestrogen and it exhibits no genotoxic activity to damage DNA. In addiction, SS5020 does not present significant uterotrophic po...

(CAS: 111112-18-6)

LY-195448 is a phenethanolamine. It blocks cells at metaphase. It has shown anti-tumour activity.

CAS 212201-70-2 Ipfencarbazone

(CAS: 212201-70-2)

Ipfencarbazone is a non-hormonal translocation-type herbicide. It is thought to inhibit the biosynthesis of very long chain fatty acids in plants. Preparations ...

Reference Reading

1.Detection and separation of nucleoside-5'-monophosphates of DNA by conjugation with the fluorescent dye BODIPY and capillary electrophoresis with laser-induced fluorescence detection.
Cornelius M1, Wörth CG, Kliem HC, Wiessler M, Schmeiser HH. Electrophoresis. 2005 Jun;26(13):2591-8.
We investigated the separation and detection of the 5'-monophosphates of 2'-deoxynucleosides selectively conjugated with 4,4-difluoro-5,7-dimethyl-4-bora-3a,4a-diaza-s-indacene-3-propionyl ethylene diamine hydrochloride (BODIPY FL EDA) at the 5'-phosphate group using capillary electrophoresis with laser-induced fluorescence detection (CE-LIF). BODIPY conjugates of the four common deoxynucleoside-5'-monophosphates (2'-deoxyguanosine-5'-monophosphate, 2'-deoxyadenosine-5'-monophosphate, 2'-deoxycytidine-5'-monophosphate, and thymidine-5'-monophosphate) were prepared and subjected to CE-LIF to serve as standard compounds for peak assignment and to develop separation conditions for the analysis of DNA. BODIPY conjugates were detected and resolved by CE-LIF after digestion of DNA or an oligonucleotide to 5'-monophosphates by nuclease P1 (NP 1) and fluorescence labeling without further purification step. Comparative analyses of calf-thymus DNA digested either with micrococcal nuclease/spleen phosphodiesterase to 3'-monophosphates or with NP 1 to 5'-monophosphates showed that both versions of the fluorescence postlabeling assay were equally efficient and sensitive.
2.Enhancement of chemotherapeutic efficacy in hypermethylator breast cancer cells through targeted and pharmacologic inhibition of DNMT3b.
Sandhu R1, Rivenbark AG, Coleman WB. Breast Cancer Res Treat. 2012 Jan;131(2):385-99. doi: 10.1007/s10549-011-1409-2. Epub 2011 Feb 27.
A subset of primary breast cancers and breast cancer cell lines express a hypermethylation defect (characterized by DNMT hyperactivity and DNMT3b overexpression) which contributes to chemotherapy resistance and provides a target for development of new treatment strategies. The objective of the current study was to determine if targeting the epigenome enhances the sensitivity of breast cancer cells to cytotoxic chemotherapy. Hypermethylator breast cancer cell lines (MDA-MB-453, BT549, and Hs578T) were treated with 250 or 500 nM 5-aza-2'-deoxycytidine (5-aza) and/or were subjected to RNAi-mediated DNMT3b knockdown (KD), and then tested for sensitivity to doxorubicin hydrochloride (DOX), paclitaxel (PAX), and 5-fluorouracil (5-FU). In MDA-MB-453 cells, DNMT3b KD reduces the IC(50) for DOX from 0.086 to 0.048 μM (44% reduction), for PAX from 0.497 to 0.376 nM (24%), and for 5-FU from 0.817 to 0.145 mM (82%). Treatment with 250 nM 5-aza for 7 days did not increase the efficacy of DOX, PAX, or 5-FU, but 7-day treatment with 500 nM 5-aza sensitized cells, reducing the IC(50) for DOX to 0.
3.Altered expression of topoisomerase IIalpha contributes to cross-resistant to etoposide K562/MX2 cell line by aberrant methylation.
Asano T1, Nakamura K, Fujii H, Horichi N, Ohmori T, Hasegawa K, Isoe T, Adachi M, Otake N, Fukunaga Y. Br J Cancer. 2005 Apr 25;92(8):1486-92.
KRN 8602 (MX2) is a novel morpholino anthracycline derivative having the chemical structure 3'-deamino-3'-morpholino-13-deoxo-10-hydroxycarminomycin hydrochloride. To investigate the mechanisms of resistance to MX2, we established an MX2-resistant phenotype (K562/MX2) of the human myelogeneous leukaemia cell line (K562/P), by continuously exposing a suspension culture to increasing concentrations of MX2. K562/MX2 cells were more resistant to MX2 than the parent cells, and also showed cross-resistance to etoposide and doxorubicin. Topoisomerase (Topo) IIalpha protein levels in K562/MX2 cells were lower of those in K562/P cells on immunoblot analysis and decreased expression of Topo IIalpha mRNA was seen in K562/MX2 cells. Topoisomerase II catalytic activity was also reduced in the nuclear extracts from K562/MX2 cells when compared with K562/P cells. Aberrant methylated CpG of Topo IIalpha gene was observed in K562/MX2 cells when compared with the parent line on methylation-specific restriction enzyme analysis.
4.One-pot two-step enzymatic coupling of pyrimidine bases to 2-deoxy-D-ribose-5-phosphate. A new strategy in the synthesis of stable isotope labeled deoxynucleosides.
Ouwerkerk N1, Steenweg M, de Ruijter M, Brouwer J, van Boom JH, Lugtenburg J, Raap J. J Org Chem. 2002 Mar 8;67(5):1480-9.
The enzymatic synthesis of thymidine from 2-deoxy-D-ribose-5-phosphate is achieved, in a one-pot two-step reaction using phosphoribomutase (PRM) and commercially available thymidine phosphorylase (TP). In the first step the sugar-5-phosphate is enzymatically rearranged to alpha-2-deoxy-D-ribose-1-phosphate. Highly active PRM is easily obtained from genetically modified overproducing E. coli cells (12,000 units/84 mg protein) and is used without further purification. In the second step thymine is coupled to the sugar-1-phosphate. The thermodynamically unfavorable equilibrium is shifted to the product by addition of MnCl(2) to precipitate inorganic phosphate. In this way the overall yield of the beta-anomeric pure nucleoside increases from 14 to 60%. In contrast to uracil, cytosine is not accepted by TP as a substrate. Therefore, 2'-deoxy-cytidine is obtained by functional group transformations of the enzymatically prepared 2'-deoxy-uridine.